Clover Health Investments에 대한 매도 수량은 투자자에게 Clover Health Investments의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Clover Health Investments (NASDAQ:CLOV) 주식, 공매도 수량 보고

Clover Health Investments

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

Trump Media & Technology, GameStop, Alibaba, Snowflake, Tesla: Why These 5 Stocks Are On Investors' Radars Today

Equities

News

Markets

CLOV

JOBY

NVDA

PLTR

TSLA

미국 주요 지수들이 수요일에 긍정적인 흐름으로 마감되었다. 다우존스 산업평균지수는 0.09% 상승하여 42,196.52로 마감했고, S&amp;P 500지수는 0.01% 상승하여 5,709.54에 도달했다. 나스닥 지수도 0.08% 상승하여 17,925.12로 마감했다.

수요일 주목받은 주식 5종목: 엔비디아, 팔란티어, 클로버 헬스, 조비 에비에이션 및 테슬라

Health Care

Movers

클로버 헬스 인베스트먼트(NASDAQ:CLOV)의 주식은 거래량이 증가하고 소셜 미디어 플랫폼 전반에 걸쳐 관심을 끌면서 수요일 29% 이상 급등했다.

클로버 헬스의 주식이 수요일 29% 이상 급등: 무슨 일이?

Clover Health Investments, Corp. - Class A Common stock

Clover Health Investments Corp

CLOVER CORP LTD by Clover Corporation Ltd.

CLOVER LEAF CAP CORP RT

Clover Finance - United States Dollar

Clover Leaf Capital Corp

Clover Leaf Capital Corp Units (1 Ord Share Class A & 1 Right)

CLOVERLEAF KENNEL CLB A by Cloverleaf Kennel Club

Cloverleaf Kennel Club

Clovis Oncology Inc

Bayer (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BAYRY#OTC">BAYRY</a>) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.38 by 71.05 percent. This is a 15.58 percent decrease over earnings of $0.77 per share from the same period last year. The company reported quarterly sales of $14.45 billion which beat the analyst consensus estimate of $13.39 billion by 7.89 percent. This is a 3.36 percent decrease over sales of $14.95 billion the same period last year.

Earnings

Earnings Beats

BAYRY

Bayer Q1 Adj. EPS $0.65 Beats $0.38 Estimate, Sales $14.45B Beat $13.39B Estimate

ITOS

Trading Halt: Halt status updated at 8:20:00 AM ET: Quotation Resumption: News and Resumption Times

Cycurion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCU#NASDAQ">CYCU</a>) ("Cycurion" or the "Company"), a trusted leader in IT cybersecurity solutions and AI, announces that it has been awarded a significant contract renewal by a major state-level public higher education group. Under this renewed agreement, Cycurion will deliver comprehensive cybersecurity services to member universities and colleges within the group, ensuring they are equipped to defend their education-focused operations and digital assets against the ever-evolving landscape of cyber threats. The renewal, valued at $33 million over the five-year term, extends Cycurion's partnership through November 2030.

CYCU

Cycurion Announces $33M Contract Renewal To Deliver Comprehensive Cybersecurity Services To State-Level Public Higher Education Institutions

Biotech

General

ONMD

OneMedNet Adopts Expanded Capabilities Within Datavant Connect Platform To Accelerate Healthcare Data Discovery, Analytics, And Partner Assessment Processes

The MoU builds on G42's growing ecosystem as it accelerates its efforts to scale AI infrastructure and innovation
ABU DHABI, UAE, May 13, 2025 /PRNewswire/ --&nbsp;G42, the UAE-based global technology group, today announced the signing of a Memorandum of Understanding (MoU) with Cisco, the global leader in networking and security, laying the groundwork for a strategic collaboration aimed at advancing artificial intelligence (AI) innovation and infrastructure development across public and private sectors.
The agreement was presented to His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi, by Peng Xiao, Group Chief Executive Officer of G42, and Chuck Robbins, Chair and Chief Executive Officer of Cisco.

CISO

G42 And Cisco Sign Strategic MOU To Extend Partnership To Drive AI Innovation And Infrastructure Development

Rosenblatt analyst Catharine Trebnick maintains CyberArk Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYBR#NASDAQ">CYBR</a>) with a Buy and maintains $445 price target.

Price Target

Analyst Ratings

CYBR

Rosenblatt Maintains Buy on CyberArk Software, Maintains $445 Price Target

&nbsp;IT Tech Packaging Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITP#NYSE">ITP</a>) ("IT Tech Packaging" or the "Company"), a leading manufacturer and distributor of diversified paper products in North China, today announced the pricing of a public offering of 6,899,500 shares of its common stock at a price to the public of $0.20 per share. The gross proceeds from the offering to IT Tech Packaging are expected to be approximately $1.4 million, before deducting offering fees and expenses. The offering is expected to close on May 14, 2025, subject to customary closing conditions.
Maxim Group LLC is acting as the sole placement agent for the offering.
IT Tech Packaging intends to use the net proceeds of this offering for working capital and other general corporate purposes.

Offerings

IT Tech Packaging Announces Pricing Of $1.4M Public Offering Of 6,899,500 Shares Of Its Common Stock At A Price To The Public Of $0.20 Per Share

NeuroOne Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMTC#NASDAQ">NMTC</a>) affirms FY2025 sales outlook from $8.00 million-$10.00 million to $8.00 million-$10.00 million.

Guidance

NMTC

NeuroOne Medical Tech Affirms FY2025 Product Revenue Guidance of $8.00M-$10.00M

Rosenblatt analyst Steve Frankel maintains Lincoln Educational Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINC#NASDAQ">LINC</a>) with a Buy and raises the price target from $24 to $25.

LINC

Rosenblatt Maintains Buy on Lincoln Educational Servs, Raises Price Target to $25

UnitedHealth Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) announced Tuesday morning that its CEO, Andrew Witty, will resign for personal reasons. The change is effective immediately.
Stephen Hemsley, who previously held the CEO title from 2006 to 2017, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45370370/unitedhealth-group-announces-leadership-transition" rel="noreferrer noopener">will succeed him</a>.
Hemsley will also remain chairman of UnitedHealth&#8217;s board of directors, and Witty will become senior adviser to the CEO.
Hemsley joined UnitedHealth Group in 1997 as chief operating officer and became president in 1999. He has been chair of the company&#8217;s board since leaving the CEO role in 2017.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/health-care/25/04/44821140/unitedhealth-demands-rapid-repayment-of-cyberattack-relief-loan-billions-providers-say-push-undermines-recovery" rel="noreferrer noopener">UnitedHealth Demands Rapid Repayment Of Cyberattack Relief Loan Billions, Providers Say Push Undermines Recovery</a>
The company also revealed that it would suspend its 2025 outlook, citing that care activity continued to accelerate.
UnitedHealth noted broadening to more types of benefit offerings than seen in the first quarter, and the medical costs of many Medicare Advantage beneficiaries new to UnitedHealthcare remained higher than expected.
It said it &#8220;expects to return to growth in 2026,&#8221; according to the announcement.
&#8220;UnitedHealth Group has tremendous opportunities to grow as we continue to help improve health care and to perform to our potential — and, in so doing, return to our long-term growth objective of 13 to 16 percent,&#8221; Hemsley continued.
The insurance giant reported adjusted EPS of $7.20 in April, up from $6.91 a year ago, missing the consensus of $7.29. Revenues increased 6.8% year over year to $109.6 billion, missing the&nbsp;<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">consensus of $111.60 billion</a>.
&#8220;UnitedHealth Group…did not perform up to our expectations, and we are aggressively addressing those challenges to position us well for the years ahead and return to our long-term earnings growth rate target of 13 to 16%,&#8221; <a target="_blank" href="https://www.benzinga.com/general/health-care/25/04/44860240/unitedhealth-slashes-2025-outlook-on-medicare-funding-reductions-stock-crashes" rel="noreferrer noopener">Witty said</a>.
Prior Guidance: UnitedHealth Group cuts its 2025 performance outlook. It expected adjusted earnings of $26.00-$26.50 per share versus&nbsp;<a target="_blank" href="https://www.benzinga.com/general/health-care/25/01/43025159/unitedhealth-q4-earnings-revenue-falls-short-medical-ratio-rises-to-85-5-stock-falls" rel="noreferrer noopener">prior guidance of 29.50-$30.00</a> per share, versus consensus of $29.73, reflecting:
<ul class="wp-block-list">
<li>Heightened care activity indications within UnitedHealthcare&#8217;s Medicare Advantage businesses became visible as the quarter closed, far above the planned 2025 increase consistent with the elevated levels in 2024, most notable within physician and outpatient services.</li>
<li>Unanticipated changes in the profile of Optum Health members are impacting planned 2025 reimbursement due to unexpectedly minimal 2024 beneficiary engagement by plans exiting markets. In addition, a greater-than-expected impact to current and new complex patients from the ongoing Medicare funding reductions enacted by the previous administration.</li>
</ul>
Price Action: At the last check on Tuesday, UNH stock was down 11% at $337.02 during the premarket session.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/biotech/25/05/45358050/nano-cap-neurosense-therapeutics-gets-14-price-forecast-as-primec-nears-key-als-milestones" target="_blank" rel="noreferrer noopener">Why This Nano-Cap Stock Might Skyrocket To $14, Per Analyst Insights</a></li>
</ul>
Photo by JHVEPhoto via Shutterstock

Large Cap

Management

UnitedHealth Names New CEO, Suspends 2025 Guidance, Stock Plunges

Optex Systems Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPXS#NASDAQ">OPXS</a>) reported quarterly earnings of $0.26 per share. This is a 62.5 percent increase over earnings of $0.16 per share from the same period last year. The company reported $10.73 million in sales this quarter. This is a 25.89 percent increase over sales of $8.52 million the same period last year.

OPXS

Optex Systems Hldgs Q2 EPS $0.26 Up From $0.16 YoY, Sales $10.73M Up From $8.52M YoY

HC Wainwright &amp; Co. analyst Kevin Dede maintains Exodus Movement (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EXOD#AMEX">EXOD</a>) with a Buy and lowers the price target from $50 to $65.

EXOD

HC Wainwright & Co. Maintains Buy on Exodus Movement, Lowers Price Target to $65

D. Boral Capital analyst Jason Kolbert maintains CervoMed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVO#NASDAQ">CRVO</a>) with a Buy and maintains $10 price target.

CRVO

D. Boral Capital Maintains Buy on CervoMed, Maintains $10 Price Target

Candel Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CADL#NASDAQ">CADL</a>) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $(0.21) by 161.9 percent. This is a 146.43 percent increase over losses of $(0.28) per share from the same period last year.

CADL

Candel Therapeutics Q1 EPS $0.13 Beats $(0.21) Estimate

Ovid Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OVID#NASDAQ">OVID</a>) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. This is a 17.65 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $130.00 thousand which beat the analyst consensus estimate of $50.00 thousand by 160.00 percent. This is a 12.16 percent decrease over sales of $148.00 thousand the same period last year.

OVID

Ovid Therapeutics Q1 EPS $(0.14), Inline, Sales $130.00K Beat $50.00K Estimate

<h3>Gainers</h3>
<ul>
<li>Lobo EV Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOBO#NASDAQ">LOBO</a>) shares increased by 106.6% to $1.57 during Tuesday's pre-market session. The market value of their outstanding shares is at $13.5 million. </li>
<li>Landsea Homes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSEA#NASDAQ">LSEA</a>) shares increased by 59.94% to $11.22. The company's market cap stands at $408.5 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Lincoln Educational Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINC#NASDAQ">LINC</a>) stock increased by 12.24% to $23.93. The market value of their outstanding shares is at $756.0 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>GigaCloud Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCT#NASDAQ">GCT</a>) shares moved upwards by 10.37% to $17.55. The company's market cap stands at $668.1 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Gogoro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GGR#NASDAQ">GGR</a>) shares rose 9.09% to $0.3. The market value of their outstanding shares is at $88.5 million. The company's, Q1 earnings came out 3 days ago. </li>
<li>CarParts.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTS#NASDAQ">PRTS</a>) shares moved upwards by 8.37% to $0.89. The market value of their outstanding shares is at $51.8 million. The company's, Q1 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Netclass Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTCL#NASDAQ">NTCL</a>) shares declined by 13.7% to $25.01 during Tuesday's pre-market session. The company's market cap stands at $445.9 million. </li>
<li>Wah Fu Education Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WAFU#NASDAQ">WAFU</a>) shares fell 11.59% to $1.45. The company's market cap stands at $6.4 million. </li>
<li>Kaixin Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KXIN#NASDAQ">KXIN</a>) stock fell 11.13% to $0.93. The market value of their outstanding shares is at $1.6 million. </li>
<li>Boqii Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BQ#AMEX">BQ</a>) shares decreased by 9.88% to $2.1. The market value of their outstanding shares is at $9.8 million. </li>
<li>Cheetah Net Supply Chain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTNT#NASDAQ">CTNT</a>) shares decreased by 7.54% to $1.35. The market value of their outstanding shares is at $4.3 million. </li>
<li>SRM Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRM#NASDAQ">SRM</a>) shares fell 7.52% to $0.41. The market value of their outstanding shares is at $6.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTNT

KXIN

LOBO

LSEA

NTCL

PRTS

WAFU

12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>CNS Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSP#NASDAQ">CNSP</a>) shares rose 90.1% to $2.3 during Tuesday's pre-market session. The market value of their outstanding shares is at $6.7 million. </li>
<li>GlucoTrack (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) shares increased by 25.15% to $0.19. The market value of their outstanding shares is at $4.7 million. </li>
<li>Xilio Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XLO#NASDAQ">XLO</a>) shares moved upwards by 23.11% to $0.9. The market value of their outstanding shares is at $46.5 million. The company's, Q1 earnings came out 3 days ago. </li>
<li>Arcturus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCT#NASDAQ">ARCT</a>) shares moved upwards by 21.22% to $14.05. The company's market cap stands at $381.0 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Silence Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLN#NASDAQ">SLN</a>) shares moved upwards by 11.22% to $4.26. The market value of their outstanding shares is at $201.1 million. As per the news, the Q1 earnings report came out 3 days ago. </li>
<li>Redhill Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDHL#NASDAQ">RDHL</a>) stock rose 10.49% to $2.21. The market value of their outstanding shares is at $3.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Polyrizon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) stock declined by 91.8% to $0.03 during Tuesday's pre-market session. </li>
<li>Sangamo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMO#NASDAQ">SGMO</a>) stock decreased by 36.8% to $0.47. The market value of their outstanding shares is at $106.0 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Accelerate Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXDX#NASDAQ">AXDX</a>) stock fell 21.63% to $0.11. The company's market cap stands at $2.6 million. </li>
<li>Klotho Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLTO#NASDAQ">KLTO</a>) shares declined by 19.73% to $0.14. The market value of their outstanding shares is at $3.9 million. </li>
<li>Coherus BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRS#NASDAQ">CHRS</a>) stock fell 16.67% to $0.85. The market value of their outstanding shares is at $98.5 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Entero Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTO#NASDAQ">ENTO</a>) shares decreased by 16.59% to $0.35. The market value of their outstanding shares is at $1.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARCT

AXDX

CHRS

CNSP

ENTO

GCTK

KLTO

PLRZ

RDHL

SGMO

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Lichen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LICN#NASDAQ">LICN</a>) shares rose 54.6% to $5.38 during Tuesday's pre-market session. The company's market cap stands at $3.2 million. </li>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) stock rose 48.15% to $0.37. The market value of their outstanding shares is at $7.8 million. </li>
<li>VirTra (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTSI#NASDAQ">VTSI</a>) shares moved upwards by 17.98% to $5.51. The company's market cap stands at $62.0 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Graphex Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GRFX#AMEX">GRFX</a>) shares rose 17.96% to $0.89. The company's market cap stands at $18.6 million. </li>
<li>Radiant Logistics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/RLGT#AMEX">RLGT</a>) shares increased by 13.89% to $7.05. The company's market cap stands at $331.4 million. As per the news, the Q3 earnings report came out yesterday. </li>
<li>VCI Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCIG#NASDAQ">VCIG</a>) shares moved upwards by 11.55% to $5.6. The market value of their outstanding shares is at $15.6 million. As per the press release, FY earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Alta Equipment Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALTG#NYSE">ALTG</a>) stock declined by 51.1% to $2.41 during Tuesday's pre-market session. The company's market cap stands at $79.9 million. The company's, Q1 earnings came out 4 days ago. </li>
<li>3D Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDD#NYSE">DDD</a>) shares decreased by 23.14% to $1.96. The market value of their outstanding shares is at $265.6 million. The company's, Q1 earnings came out yesterday. </li>
<li>Lakeside Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSH#NASDAQ">LSH</a>) shares fell 17.61% to $0.89. The company's market cap stands at $6.6 million. </li>
<li>Marwynn Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MWYN#NASDAQ">MWYN</a>) shares declined by 16.18% to $6.01. The company's market cap stands at $102.4 million. </li>
<li>Vast Renewables (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTE#NASDAQ">VSTE</a>) stock fell 11.37% to $0.12. The market value of their outstanding shares is at $3.5 million. </li>
<li>Perma-Pipe Inlt Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPIH#NASDAQ">PPIH</a>) stock decreased by 11.24% to $12.01. The company's market cap stands at $95.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALTG

GRFX

LICN

MWYN

PPIH

RLGT

VCIG

VSTE

VTSI

WLGS

12 Industrials Stocks Moving In Tuesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Gryphon Digital Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>) shares moved upwards by 16.2% to $1.65 during Tuesday's pre-market session. The market value of their outstanding shares is at $114.4 million. </li>
<li>Iveda Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVDA#NASDAQ">IVDA</a>) stock increased by 13.12% to $2.5. The company's market cap stands at $7.0 million. </li>
<li>MicroAlgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) stock increased by 10.54% to $3.46. The market value of their outstanding shares is at $34.5 million. </li>
<li>Alpha Modus Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMOD#NASDAQ">AMOD</a>) stock rose 10.44% to $1.48. The company's market cap stands at $18.4 million. </li>
<li>Taoping (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TAOP#NASDAQ">TAOP</a>) stock rose 8.13% to $0.32. The company's market cap stands at $4.2 million. </li>
<li>Roadzen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDZN#NASDAQ">RDZN</a>) shares moved upwards by 7.8% to $0.84. The company's market cap stands at $62.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Everspin Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRAM#NASDAQ">MRAM</a>) stock decreased by 13.8% to $5.26 during Tuesday's pre-market session. The market value of their outstanding shares is at $115.5 million. </li>
<li>Exodus Movement (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EXOD#AMEX">EXOD</a>) shares fell 11.61% to $48.0. The company's market cap stands at $1.3 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Indie Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDI#NASDAQ">INDI</a>) shares fell 11.39% to $2.34. The company's market cap stands at $458.9 million. The company's, Q1 earnings came out yesterday. </li>
<li>Rigetti Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) shares declined by 11.35% to $10.24. The company's market cap stands at $2.9 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Abits Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABTS#NASDAQ">ABTS</a>) shares decreased by 10.29% to $3.4. The company's market cap stands at $8.0 million. </li>
<li>Microvision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) stock fell 9.1% to $1.1. The market value of their outstanding shares is at $270.3 million. As per the press release, Q1 earnings came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABTS

AMOD

GRYP

INDI

IVDA

MLGO

MRAM

MVIS

RDZN

RGTI

TAOP

12 Information Technology Stocks Moving In Tuesday's Pre-Market Session

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates FibroGen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGEN#NASDAQ">FGEN</a>) with a Buy and maintains $10 price target.

Reiteration

FGEN

HC Wainwright & Co. Reiterates Buy on FibroGen, Maintains $10 Price Target

Press Releases

Counterpart Health Partners with Google Cloud to Improve Clinical Data Access for Physicians

Clover Health Appoints Industry Veteran as Chief Medical Officer of Medicare Advantage

Clover Health to Report First Quarter 2025 Financial Results on May 6, 2025

Clover Health to Participate in Upcoming Investor Conferences

Clover Health Announces Changes to Board of Directors

Small Cap

Opinion

New Advances in Healthcare AI Could Unlock Billions in Market Opportunity

Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure

Tech That Listens, Learns, and Diagnoses: AI's Breakout Moment in Healthcare

Clover Health Reports First Quarter 2025 Results and Improves Full Year 2025 Guidance

Comments

Clover Health Investments

매도 수량

Clover Health Investments (NASDAQ:CLOV) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌